Isolation, chemotaxonomic significance and cytotoxic effects of quassinoids from Brucea java']javanica

被引:28
作者
Ye, Qing-Mei [1 ,2 ]
Bai, Liang-Liang [1 ]
Hu, Shu-Zhi [1 ]
Tian, Hai-Yan [1 ]
Ruan, Li-Jun [1 ]
Tan, Ya-Fang [1 ]
Hu, Li-Ping [1 ]
Ye, Wen-Cai [1 ]
Zhang, Dong-Mei [1 ,3 ]
Jiang, Ren-Wang [1 ,3 ]
机构
[1] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China
[2] Hainan Gen Hosp, Dept Pharm, Haikou 570311, Peoples R China
[3] Shenzhen Inst Drug Control, Shenzhen Engn Lab Lingnan Med Resources Dev & App, Shenzhen 518057, Peoples R China
关键词
Brucea [!text type='java']java[!/text]nica; Quassinoids; Bruceene A; Breast cancer; Chemotaxonomics; CHEMICAL-CONSTITUENTS; L; MERR; GLYCOSIDES; APOPTOSIS; BRUSATOL; CELLS; SEEDS; INHIBITORS; AUTOPHAGY; AGENTS;
D O I
10.1016/j.fitote.2015.06.004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new quassinoid, bruceene A (1) along with seventeen known quassinoids (2-18) was isolated from the fruits of Brucea javanica. The structure of 1 was elucidated by extensive spectroscopic methods, and was further confirmed by single-crystal X-ray diffraction analysis. Isolation of similar quassinoids 1-3 as those in genus Ailanthus from genus Bruce a, indicated the close chemotaxonomic relationship between these two genera, which further supported the phylogenetic study by DNA analysis. Compounds 5, 7, 10 and 12 with a 3-hydroxy-3-en-2-one moiety showed potent inhibitory activities against the MCF-7 and MDA-MB-231 cells with IC50 values in the ranges 0.063-0.182 mu M and 0.081-0.238 mu M, respectively; while glycosidation at 3-OH significantly decreased the cytotoxicity. It was also found that the most potent compound 7 induced apoptosis in MCF-7 cells via the intrinsic mitochondrial apoptotic pathway. (C) 2015 Elsevier BY. All rights reserved.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 30 条
  • [1] Clayton, 2008, THESIS U FLORIDA
  • [2] Brusatol-induced HL-60 cell differentiation involves NF-κB activation
    Cuendet, M
    Gills, JJ
    Pezzuto, JM
    [J]. CANCER LETTERS, 2004, 206 (01) : 43 - 50
  • [3] Darwish F.A., 1979, J PHARM PHARMACOL, V31, P10
  • [4] Editorial Committee of Pharmacopoeia, 2010, PHARM CHIN, P238
  • [5] Quassinoids: From Traditional Drugs to New Cancer Therapeutics
    Fiaschetti, G.
    Grotzer, M. A.
    Shalaby, T.
    Castelletti, D.
    Arcaro, A.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (03) : 316 - 328
  • [6] SPECTROSCOPIC STUDIES OF BRUSATOL
    HARIGAYA, Y
    KONDA, Y
    IGUCHI, M
    ONDA, M
    LI, X
    WU, LJ
    LI, SS
    SUN, XL
    [J]. JOURNAL OF NATURAL PRODUCTS, 1989, 52 (04): : 740 - 748
  • [7] Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
    Kang, Min H.
    Reynolds, C. Patrick
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1126 - 1132
  • [8] Kim JA, 2010, ANTICANCER RES, V30, P3295
  • [9] ANTI-TUMOR AGENTS .33. ISOLATION AND STRUCTURAL ELUCIDATION OF BRUCEOSIDE-A AND BRUCEOSIDE-B, NOVEL ANTI-LEUKEMIC QUASSINOID GLYCOSIDES, AND BRUCEIN-D AND BRUCEIN-E FROM BRUCEA-JAVA']JAVANICA
    LEE, KH
    IMAKURA, Y
    SUMIDA, Y
    WU, RY
    HALL, IH
    HUANG, HC
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1979, 44 (13) : 2180 - 2185
  • [10] BRUCEINE-D, BRUCEINE-E AND BRUCEINE-H
    LI, X
    WU, LJ
    KONDA, Y
    IGUCHI, M
    TAKAHASI, H
    HARIGAYA, Y
    ONDA, M
    [J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 1989, 26 (02) : 493 - 501